Cargando…
Enhancement of the activity of phenoxodiol by cisplatin in prostate cancer cells
Phenoxodiol is a novel isoflav-3-ene, currently undergoing clinical trials, that has a broad in vitro activity against a number of human cancer cell lines. Phenoxodiol alone inhibited DU145 and PC3 in a dose- and time-dependent manner with IC(50) values of 8±1 and 38±9 μM, respectively. The combinat...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
2009
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2653737/ https://www.ncbi.nlm.nih.gov/pubmed/19209173 http://dx.doi.org/10.1038/sj.bjc.6604920 |